Andoh A - Search Results

1

IL12B rs6887695 polymorphism and interaction with alcohol intake in the risk of ulcerative colitis in Japan.

Miyake Y, Tanaka K, Nagata C, Furukawa S, Andoh A, Yokoyama T, Yoshimura N, Mori K, Ninomiya T, Yamamoto Y, Takeshita E, Ikeda Y, Saito M, Ohashi K, Imaeda H, Kakimoto K, Higuchi K, Nunoi H, Mizukami Y, Suzuki S, Hiraoka S, Okada H, Kawasaki K, Higashiyama M, Hokari R, Miura H, Miyake T, Kumagi T, Kato H, Hato N, Sayama K, Hiasa Y; Japan Ulcerative Colitis Study Group. Miyake Y, et al. Among authors: andoh a. Cytokine. 2022 Jul;155:155901. doi: 10.1016/j.cyto.2022.155901. Epub 2022 May 11. Cytokine. 2022. PMID: 35567898

2

An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.

Sakuraba A, Motoya S, Watanabe K, Nishishita M, Kanke K, Matsui T, Suzuki Y, Oshima T, Kunisaki R, Matsumoto T, Hanai H, Fukunaga K, Yoshimura N, Chiba T, Funakoshi S, Aoyama N, Andoh A, Nakase H, Mizuta Y, Suzuki R, Akamatsu T, Iizuka M, Ashida T, Hibi T. Sakuraba A, et al. Among authors: andoh a. Am J Gastroenterol. 2009 Dec;104(12):2990-5. doi: 10.1038/ajg.2009.453. Epub 2009 Sep 1. Am J Gastroenterol. 2009. PMID: 19724269 Clinical Trial.

3

The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease.

Sugihara T, Kobori A, Imaeda H, Tsujikawa T, Amagase K, Takeuchi K, Fujiyama Y, Andoh A. Sugihara T, et al. Among authors: andoh a. Clin Exp Immunol. 2010 Jun;160(3):386-93. doi: 10.1111/j.1365-2249.2010.04093.x. Epub 2010 Jan 19. Clin Exp Immunol. 2010. PMID: 20089077 Free PMC article.

4

The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease.

Ban H, Andoh A, Imaeda H, Kobori A, Bamba S, Tsujikawa T, Sasaki M, Saito Y, Fujiyama Y. Ban H, et al. Among authors: andoh a. J Gastroenterol. 2010 Oct;45(10):1014-21. doi: 10.1007/s00535-010-0248-y. J Gastroenterol. 2010. PMID: 20393862

5

Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis.

Kobori A, Yagi Y, Imaeda H, Ban H, Bamba S, Tsujikawa T, Saito Y, Fujiyama Y, Andoh A. Kobori A, et al. Among authors: andoh a. J Gastroenterol. 2010 Oct;45(10):999-1007. doi: 10.1007/s00535-010-0245-1. Epub 2010 Apr 20. J Gastroenterol. 2010. PMID: 20405148

6

Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis.

Andoh A, Imaeda H, Aomatsu T, Inatomi O, Bamba S, Sasaki M, Saito Y, Tsujikawa T, Fujiyama Y. Andoh A, et al. J Gastroenterol. 2011 Apr;46(4):479-86. doi: 10.1007/s00535-010-0368-4. Epub 2011 Jan 21. J Gastroenterol. 2011. PMID: 21253779

7

The DPP-IV inhibitor ER-319711 has a proliferative effect on the colonic epithelium and a minimal effect in the amelioration of colitis.

Ban H, Bamba S, Imaeda H, Inatomi O, Kobori A, Sasaki M, Tsujikawa T, Andoh A, Fujiyama Y. Ban H, et al. Among authors: andoh a. Oncol Rep. 2011 Jun;25(6):1699-703. doi: 10.3892/or.2011.1223. Epub 2011 Mar 22. Oncol Rep. 2011. PMID: 21431278

8

Interleukin-33 suppresses Notch ligand expression and prevents goblet cell depletion in dextran sulfate sodium-induced colitis.

Imaeda H, Andoh A, Aomatsu T, Uchiyama K, Bamba S, Tsujikawa T, Naito Y, Fujiyama Y. Imaeda H, et al. Among authors: andoh a. Int J Mol Med. 2011 Oct;28(4):573-8. doi: 10.3892/ijmm.2011.718. Epub 2011 Jun 8. Int J Mol Med. 2011. PMID: 21667014

9

The severity of dextran sodium sulfate-induced colitis can differ between dextran sodium sulfate preparations of the same molecular weight range.

Bamba S, Andoh A, Ban H, Imaeda H, Aomatsu T, Kobori A, Mochizuki Y, Shioya M, Nishimura T, Inatomi O, Sasaki M, Saitoh Y, Tsujikawa T, Araki Y, Fujiyama Y. Bamba S, et al. Among authors: andoh a. Dig Dis Sci. 2012 Feb;57(2):327-34. doi: 10.1007/s10620-011-1881-x. Epub 2011 Sep 8. Dig Dis Sci. 2012. PMID: 21901260

10

Expression of interleukin-24 and its receptor in human pancreatic myofibroblasts.

Imaeda H, Nishida A, Inatomi O, Fujiyama Y, Andoh A. Imaeda H, et al. Among authors: andoh a. Int J Mol Med. 2011 Dec;28(6):993-9. doi: 10.3892/ijmm.2011.793. Epub 2011 Sep 12. Int J Mol Med. 2011. PMID: 21922126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

507 results

Search Page